Six things to know:
- The lab is a partnership between Amazon, AstraZeneca, Merck, Pfizer and Teva, according to a news release. Rehovot, Israel has been selected as its international headquarters.
- The lab will be powered by AWS, and produce artificial intelligence and computational ventures to develop new pharmaceutical therapies.
- The facility will include both a wet lab for biomedical research and a cloud-based computational lab.
- The lab will create and invest in startups that develop new technology, treatments and approaches for healthcare.
- Mati Gill, former Teva COO, was appointed CEO of AION Labs. Yair Benita, PhD, former principal scientist at Merck, was named chief technology officer.
- The lab’s budget is set at $9.9 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.